0001567619-20-011697.txt : 20200604 0001567619-20-011697.hdr.sgml : 20200604 20200604160037 ACCESSION NUMBER: 0001567619-20-011697 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200604 DATE AS OF CHANGE: 20200604 EFFECTIVENESS DATE: 20200604 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Elucida Oncology, Inc. CENTRAL INDEX KEY: 0001704594 IRS NUMBER: 471358366 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-367640 FILM NUMBER: 20942921 BUSINESS ADDRESS: STREET 1: 228 PARK AVENUE SOUTH CITY: NEW YORK STATE: NY ZIP: 10003 BUSINESS PHONE: 805-691-9355 MAIL ADDRESS: STREET 1: 228 PARK AVENUE SOUTH CITY: NEW YORK STATE: NY ZIP: 10003 D/A 1 primary_doc.xml X0708 D/A LIVE 0001704594 Elucida Oncology, Inc. 1 Deer Park Drive Suite E Monmouth Junction NJ NEW JERSEY 08852 646-701-5391 DELAWARE Claymore Technologies Inc. None Corporation true Geno Germano 1 Deer Park Drive Suite E Monmouth Junction NJ NEW JERSEY 08852 Executive Officer Director Tim Boris 1 Deer Park Drive Suite E Monmouth Junction NJ NEW JERSEY 08852 Director Michael Smith 1 Deer Park Drive Suite E Monmouth Junction NJ NEW JERSEY 08852 Director Robert Essner 1 Deer Park Drive Suite E Monmouth Junction NJ NEW JERSEY 08852 Executive Officer Director Teresa Ressel 1 Deer Park Drive Suite E Monmouth Junction NJ NEW JERSEY 08852 Director Ulrich Wiesner 1 Deer Park Drive Suite E Monmouth Junction NJ NEW JERSEY 08852 Director Robert Ruffolo 1 Deer Park Drive Suite E Monmouth Junction NJ NEW JERSEY 08852 Director Biotechnology No Revenues 06b true 0001567619-20-011117 2020-05-13 false true true false 11400 Maxim Group LLC 12078 None None 405 Lexington Avenue New York NY NEW YORK 10174 All States false 30000000 8782683 21217317 false 126 774072 0 In addition, the Company issued the placement agent Warrants to purchase 1,150,096 shares of common stock of Elucida in connection with the offering. 0 false Elucida Oncology, Inc. /s/ Geno Germano Geno Germano CEO 2020-06-04